奨励歩行は慢性疾患の指標を改善する:中国南東部の職業人口の間で短期間のフィールド介入
Xiangju Hu1,2, Menglin Yu1, Zhifeng Lin1
1Fujian Provincial Key Laboratory of Environment Factors and Cancer, Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.
Frontiers in public health
|February 12, 2026
まとめ
100日間の奨励歩行プログラムにより,職業コホートにおける慢性疾患の指標が改善されました. 歩行強度の上昇は,血圧,体重,体質の改善と相関しており,職場の健康戦略を支えている.
科学分野:
- 職業衛生は,健康に関するものです.
- 予防医学は,予防的な医療です.
- 公衆衛生は公衆衛生である.
背景:
- 慢性疾患は,公衆衛生上の大きな課題となっています.
- 職場での介入は,従業員の健康と幸福を促進するために不可欠です.
- 職業環境は,効果的な慢性疾患予防戦略を実施するための機会を提供します.
研究 の 目的:
- 慢性疾患の指標に対する短期的な,奨励された歩行介入の影響を評価する.
- 職業コホート内で慢性疾患の予防と制御のための効果的な戦略を探求する.
- 歩行強度と健康指標の改善との関係を評価する.
主な方法:
- 100日間の監督された歩行介入で,個人およびチームのインセンティブがあります.
- ステップカウントは,均一な歩数計を使用して監視されます.
- アントロポメトリック測定値 (身長,体重,腰・腰周,腰・腰比,体脂肪率) をベースラインとエンドポイントで収集する.
- SPSS 26.0.0.を使用したデータ分析.
主要な成果:
- すべての参加者が介入を完了し,64.2%が1日1万歩の目標を達成しました.
- 男性と女性の両方の8つの慢性疾患の指標で顕著な改善が観察されました.
- シストリック血圧 (2.47 mmHg),ダイアストリック血圧 (4.23 mmHg),体重 (1.60 kg),BMI (0.57 kg/m2),腰周長 (1.33 cm),股関節周長 (0.86 cm),腰と股関節の比率 (0.01),体脂肪率 (0.01%) の減少が観察されました.
- 歩行強度と健康指標の改善の間の用量依存関係が明らかでした.
結論:
- 短期的なウォーキング介入は,血圧,BMI,腰周,体脂肪率を含む主要な身体指標を大幅に改善しました.
- BMIと腰周数の顕著な減少は,介入の有効性を強調しています.
- 研究結果は,非伝染性疾患のリスクを軽減するために職場の健康戦略を統合することを支持し,さらなる制御された研究が待っている.
関連する概念動画
Indicators
61.1K
Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
61.1K
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Kidney Disease I: Introduction
766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
Chronic Kidney Disease II: Clinical Manifestations
683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683


